BIOPTIMATE ApS: Financial statements 2017
CVR: 36051183
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
BIOPTIMATE ApS (CVR 36051183) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -19,801 and a net result of DKK -24,306 compared with DKK 39,293 the year before. Equity in the 2017 report amounted to DKK 74,931. The solvency ratio was 77.4%.
- Gross Profit
- DKK -19,801
- Profit/Loss
- DKK -24,306
- Equity
- DKK 74,931
- Total Assets
- DKK 96,829
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -20 t. | -24 t. | 75 t. | - |
| 2016 | - | -13 t. | 39 t. | 99 t. | - |
Keep an eye on BIOPTIMATE ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
BIOPTIMATE ApS has published its annual report for 2016. Gross profit came to DKK -12,720, and the net result was DKK 39,293.
About BIOPTIMATE ApS
BIOPTIMATE ApS is a Danish company of the type Anpartsselskab based in Birkerød, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jens Christian Sørensen. The company is owned by Pure20 ApS. In 2025, the company reported a gross profit of DKK -1,252,436 and a net result of DKK -1,858,649 compared with DKK -6,367,118 the year before. Equity in the 2025 report amounted to DKK -5,714,314.